| Mohammed Jaweed, FNP-C | |
|
1710 Harper Rd, Beckley, WV 25801-3357 | |
| (304) 256-4100 | |
| Not Available |
| Full Name | Mohammed Jaweed |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner |
| Experience | 6 Years |
| Location | 1710 Harper Rd, Beckley, West Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164987574 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | 71609-NP-C (West Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Raleigh General Hospital | Beckley, WV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cherokee Emergency Services Inc | 2961396122 | 5 |
News Archive
Laboratory Corporation of America Holdings announced today a collaboration between Esoterix Clinical Trials Services, a division of LabCorp, and Clearstone Central Laboratories, a global central laboratory specializing in drug development and pharmaceutical services.
AlphaRx Inc. announced today that it has signed an agreement that provides long-term supply of the active pharmaceutical ingredient (API) for ARX1088, an orally active interferon inducer intended for the adjunctive treatment of Hepatitis in China and other emerging markets. Under the agreement, Venturepharm will be the primary supplier of AlphaRx's worldwide requirements for the compound.
Ranbaxy Pharmaceuticals has announced approval from the U.S. Food and Drug Administration to manufacture and market Quinapril Hydrochloride & Hydrochlorothiazide (Quinapril + HCTZ) Tablets, 10mg/12.5mg, 20mg/12.5mg and 20mg/25mg.
Spinifex Pharmaceuticals, an Australian pain drug development company, today announces positive headline results from the Phase 2 clinical trial of its lead product, EMA401, in postherpetic neuralgia (PHN), a painful condition that develops in some patients following herpes zoster (shingles) and where existing therapy does not relieve pain in all individuals.
Breast cancer patients who received the combination of a nerve block with general anesthesia for their breast cancer surgery had less cancer recurrence and were three times less likely to die than those who received only general anesthesia, according to a study presented at the ANESTHESIOLOGY 2013 annual meeting.
› Verified 2 days ago
| Entity Name | Cherokee Emergency Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982643938 PECOS PAC ID: 2961396122 Enrollment ID: O20040210000492 |
News Archive
Laboratory Corporation of America Holdings announced today a collaboration between Esoterix Clinical Trials Services, a division of LabCorp, and Clearstone Central Laboratories, a global central laboratory specializing in drug development and pharmaceutical services.
AlphaRx Inc. announced today that it has signed an agreement that provides long-term supply of the active pharmaceutical ingredient (API) for ARX1088, an orally active interferon inducer intended for the adjunctive treatment of Hepatitis in China and other emerging markets. Under the agreement, Venturepharm will be the primary supplier of AlphaRx's worldwide requirements for the compound.
Ranbaxy Pharmaceuticals has announced approval from the U.S. Food and Drug Administration to manufacture and market Quinapril Hydrochloride & Hydrochlorothiazide (Quinapril + HCTZ) Tablets, 10mg/12.5mg, 20mg/12.5mg and 20mg/25mg.
Spinifex Pharmaceuticals, an Australian pain drug development company, today announces positive headline results from the Phase 2 clinical trial of its lead product, EMA401, in postherpetic neuralgia (PHN), a painful condition that develops in some patients following herpes zoster (shingles) and where existing therapy does not relieve pain in all individuals.
Breast cancer patients who received the combination of a nerve block with general anesthesia for their breast cancer surgery had less cancer recurrence and were three times less likely to die than those who received only general anesthesia, according to a study presented at the ANESTHESIOLOGY 2013 annual meeting.
› Verified 2 days ago
| Entity Name | Alwahhab Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942620182 PECOS PAC ID: 7618194911 Enrollment ID: O20140811001014 |
News Archive
Laboratory Corporation of America Holdings announced today a collaboration between Esoterix Clinical Trials Services, a division of LabCorp, and Clearstone Central Laboratories, a global central laboratory specializing in drug development and pharmaceutical services.
AlphaRx Inc. announced today that it has signed an agreement that provides long-term supply of the active pharmaceutical ingredient (API) for ARX1088, an orally active interferon inducer intended for the adjunctive treatment of Hepatitis in China and other emerging markets. Under the agreement, Venturepharm will be the primary supplier of AlphaRx's worldwide requirements for the compound.
Ranbaxy Pharmaceuticals has announced approval from the U.S. Food and Drug Administration to manufacture and market Quinapril Hydrochloride & Hydrochlorothiazide (Quinapril + HCTZ) Tablets, 10mg/12.5mg, 20mg/12.5mg and 20mg/25mg.
Spinifex Pharmaceuticals, an Australian pain drug development company, today announces positive headline results from the Phase 2 clinical trial of its lead product, EMA401, in postherpetic neuralgia (PHN), a painful condition that develops in some patients following herpes zoster (shingles) and where existing therapy does not relieve pain in all individuals.
Breast cancer patients who received the combination of a nerve block with general anesthesia for their breast cancer surgery had less cancer recurrence and were three times less likely to die than those who received only general anesthesia, according to a study presented at the ANESTHESIOLOGY 2013 annual meeting.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mohammed Jaweed, FNP-C 210 E St, Beckley, WV 25801-6504 Ph: (304) 237-7105 | Mohammed Jaweed, FNP-C 1710 Harper Rd, Beckley, WV 25801-3357 Ph: (304) 256-4100 |
News Archive
Laboratory Corporation of America Holdings announced today a collaboration between Esoterix Clinical Trials Services, a division of LabCorp, and Clearstone Central Laboratories, a global central laboratory specializing in drug development and pharmaceutical services.
AlphaRx Inc. announced today that it has signed an agreement that provides long-term supply of the active pharmaceutical ingredient (API) for ARX1088, an orally active interferon inducer intended for the adjunctive treatment of Hepatitis in China and other emerging markets. Under the agreement, Venturepharm will be the primary supplier of AlphaRx's worldwide requirements for the compound.
Ranbaxy Pharmaceuticals has announced approval from the U.S. Food and Drug Administration to manufacture and market Quinapril Hydrochloride & Hydrochlorothiazide (Quinapril + HCTZ) Tablets, 10mg/12.5mg, 20mg/12.5mg and 20mg/25mg.
Spinifex Pharmaceuticals, an Australian pain drug development company, today announces positive headline results from the Phase 2 clinical trial of its lead product, EMA401, in postherpetic neuralgia (PHN), a painful condition that develops in some patients following herpes zoster (shingles) and where existing therapy does not relieve pain in all individuals.
Breast cancer patients who received the combination of a nerve block with general anesthesia for their breast cancer surgery had less cancer recurrence and were three times less likely to die than those who received only general anesthesia, according to a study presented at the ANESTHESIOLOGY 2013 annual meeting.
› Verified 2 days ago
Mr. Landon J Blankenship, APRN, FNP-BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 456 Cranberry Dr, Beckley, WV 25801 Phone: 304-255-6404 Fax: 304-255-6494 | |
Mrs. Jennifer Elizabeth Poff, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 250 Stanaford Rd, Beckley, WV 25801 Phone: 304-254-2634 Fax: 304-254-2664 | |
Debra L Mcgraw, CFNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1802 Harper Rd, Suite 102, Beckley, WV 25801 Phone: 304-252-9211 Fax: 304-252-9218 | |
Adam L Meade, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 4130 Robert C. Byrd Drive, Beckley, WV 25801 Phone: 273-326-3337 | |
Jennifer N Lambert, N.P. Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 306 Stanaford Rd, Beckley, WV 25801 Phone: 304-255-3000 Fax: 954-625-6034 | |
Rosalind Rebecca Berry, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 275 Dry Hill Road, Beckley, WV 25801 Phone: 304-253-6060 Fax: 304-929-2248 | |
Traci Lynn Morris, NP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 101 S Eisenhower Dr, Beckley, WV 25801 Phone: 304-256-7100 Fax: 304-256-7111 |